Scarica l'app Stockscreener
151.16
1.07%
1.60
Dopo l'orario di chiusura:
151.16
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BDX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$149.56
Aprire:
$151.78
Volume 24 ore:
2.08M
Relative Volume:
0.75
Capitalizzazione di mercato:
$41.65B
Reddito:
$21.37B
Utile/perdita netta:
$1.41B
Rapporto P/E:
38.33
EPS:
3.9437
Flusso di cassa netto:
$3.07B
1 W Prestazione:
+2.75%
1M Prestazione:
+4.85%
6M Prestazione:
-22.07%
1 anno Prestazione:
-11.62%
Intervallo 1D:
$150.70
$153.24
Intervallo di 1 settimana:
$143.13
$153.24
Portata 52W:
$141.82
$213.08
Becton Dickinson Co Stock (BDX) Company Profile
Nome
Becton Dickinson Co
Settore
Industria
Telefono
(201) 847-6800
Indirizzo
ONE BECTON DR, FRANKLIN LAKES
Compare BDX vs ISRG, ALC, RMD, MDLN
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
151.16 | 41.21B | 21.37B | 1.41B | 3.07B | 3.9437 |
ISRG
Intuitive Surgical Inc
|
422.06 | 148.33B | 10.58B | 3.00B | 2.83B | 8.2437 |
ALC
Alcon Inc
|
66.81 | 32.47B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
196.04 | 28.19B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
33.61 | 29.13B | 29.14B | 1.07B | 1.05B | 1.1956 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-10 | Ripresa | Goldman | Neutral |
| 2026-02-10 | Ripresa | Barclays | Overweight |
| 2026-02-03 | Ripresa | Citigroup | Buy |
| 2025-09-25 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2025-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2025-05-02 | Downgrade | Goldman | Buy → Neutral |
| 2025-05-02 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-05-02 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2025-05-01 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-05-01 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-05-01 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2023-07-24 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-05-05 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-04-12 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-03 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-12-12 | Aggiornamento | Citigroup | Sell → Neutral |
| 2022-07-11 | Downgrade | Citigroup | Neutral → Sell |
| 2022-06-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-03-18 | Ripresa | Raymond James | Mkt Perform |
| 2022-03-02 | Ripresa | BofA Securities | Neutral |
| 2021-12-08 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-08-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2020-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-12-15 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-07-09 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-06-01 | Ripresa | Goldman | Buy |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-07 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-02-07 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-07 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2020-02-06 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-01-08 | Downgrade | Barclays | Overweight → Equal Weight |
| 2019-05-13 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2018-12-07 | Iniziato | Deutsche Bank | Buy |
| 2018-10-16 | Iniziato | Barclays | Equal Weight |
| 2018-06-21 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-04-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-01-19 | Ripresa | BofA/Merrill | Buy |
| 2018-01-05 | Aggiornamento | Citigroup | Sell → Neutral |
| 2018-01-05 | Iniziato | KeyBanc Capital Mkts | Overweight |
| 2018-01-03 | Iniziato | Evercore ISI | Outperform |
| 2017-12-29 | Reiterato | Deutsche Bank | Buy |
Mostra tutto
Becton Dickinson Co Borsa (BDX) Ultime notizie
Jim Cramer on Becton, Dickinson: “I Think You Buy Some and Then You Wait” - Insider Monkey
Becton Dickinson earnings loom as investors eye post-divestiture growth By Investing.com - Investing.com
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
Deals tracker: Tennessee senior care operator spends $50M for 5 facilities - Modern Healthcare
Becton Dickinson & Co. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Becton Dickinson chairman, CEO Thomas E. Polen Jr. sells $404k in shares - Investing.com UK
Wound Irrigation Systems Market to Skyrocket USD 430.05 Million by 2035 as Chronic Wound Cases and Surgical Volumes Rise Worldwide | SNS Insider - GlobeNewswire Inc.
Becton Dickinson & Co. stock outperforms competitors despite losses on the day - MarketWatch
Becton Dickinson & Co stock (US0758871091): Norges Bank stake highlights interest after recent earni - AD HOC NEWS
Becton, Dickinson And Company (BDX) Stock Analysis: Exploring A 23% Upside Potential - DirectorsTalk Interviews
TD Cowen Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $163 - 富途牛牛
Becton Dickinson resumes U.S. shipments of ChloraPrep after additional testing - TradingView
Here’s Hinde Group’s Updates on Becton, Dickinson and Company (BDX) - Insider Monkey
Piper Sandler Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $161 - Moomoo
Insider Sell: Michael Feld Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus
Becton Dickinson EVP Michael Feld sells $11,051 in stock - Investing.com UK
Becton Dickinson EVP Michael Feld sells $11,051 in stock By Investing.com - Investing.com UK
Goldman Sachs Adjusts PT on Becton, Dickinson and Co. to $150 From $156, Maintains Neutral Rating - Moomoo
Becton, Dickinson And Company (BDX): Evaluating Growth Potential With A 24% Upside - DirectorsTalk Interviews
Elyra Kidney Stone Laser Launch Tests Becton Dickinson Execution Story - simplywall.st
Becton, Dickinson & Co. Faces Valuation Shift Amid Declining Stock Returns and High Debt - Markets Mojo
BD Delivers Kidney Stone Care for Urology Teams with the Elyra Thulium Fiber Laser System - Finviz
New BD laser targets smoother, quieter kidney stone care procedures - Stock Titan
Becton Dickinson and Co stock (US0758871091): new €600 million notes and recent loss raise questio - AD HOC NEWS
Becton, Dickinson and Company (BDX) Announces €600 Million Notes Offering - GuruFocus
Becton Dickinson Euro Finance Issues €600 Million 3.855% Notes Due 2033 Guaranteed by BD - Minichart
Becton Dickinson subsidiary issues €600 million in 3.855% notes due 2033 - Investing.com Canada
Becton Dickinson Issues €600 Million 3.855% Notes Due 2033 to Refinance 2026 Debt - TradingView
A Look at Becton Dickinson & Co (BDX) After 3.2% Gain -- GF Value $194.45 vs Price $146.95 - GuruFocus
Nebulizers - GlobeNewswire Inc.
Is Wall Street Bullish or Bearish on Becton, Dickinson and Company Stock? - Barchart.com
BD Names Peter Menziuso to Lead $BD Interventional Business - citybiz
Becton, Dickinson and Company Appoints Peter Menziuso as Executive Vice President and President, Bd Interventional, Effective June 1, 2026 - marketscreener.com
Becton, Dickinson and Company (BDX) Stock Analysis: Unveiling a 27.75% Potential Upside - DirectorsTalk Interviews
Becton Dickinson hikes profit outlook, names CFO - MSN
Becton Dickinson and Co stock (US0758871091): earnings beat and strategic focus keep medtech giant i - AD HOC NEWS
DNB Asset Management AS Has $22.28 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
Northwestern Mutual Wealth Management Co. Increases Stock Position in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson (BDX) Delivers Solid Q2 Performance, Barclays Lifts Target - Insider Monkey
Becton Dickinson & Co(BDX) Stock Options Chain | Quotes & News - Moomoo
Becton Dickinson's (NYSE:BDX) Strong Earnings Are Of Good Quality - Moomoo
Becton Dickinson and Co stock (US0758871091): Drops 2.4% to $143.97 after earnings - AD HOC NEWS
Jim Cramer Makes Big Claim About Beckton Dickinson (BDX) - Yahoo Finance
Becton Dickinson & Co. stock underperforms Wednesday when compared to competitors - MarketWatch
Becton Dickinson Co Azioni (BDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Becton Dickinson Co Azioni (BDX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Polen Thomas E Jr | Chairman, CEO and President |
Jun 01 '26 |
Sale |
146.35 |
2,764 |
404,511 |
110,163 |
0.35%
2.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):